The risks included above are not exhaustive. The most recent reports on Form 10-K, Form 10-Q, Form 8-K and other periodic reports filed by Renovis with the Securities and Exchange Commission contain additional factors that could impact the combined company's businesses and financial performance. The parties expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the parties' expectations or any change in events, conditions or circumstances on which any such statement is based.
Renovis has filed a Current Report on Form 8-K that includes as an
exhibit the Agreement and Plan of Merger between Evotec and Renovis. Evotec
has filed a Registration Statement on Form F-4 with the Securities and
Exchange Commission in connection with the proposed merger. Evotec and
Renovis expect to mail a joint proxy statement/prospectus, which will form
part of the Registration Statement on Form F-4, to shareholders of Renovis
in connection with the proposed merger. This document will contain
important information about the merger and should be read before any
decision is made with respect to the merger. Investors and stockholders
will be able to obtain free copies of this document and any other documents
filed or furnished by Evotec or Renovis through the website maintained by
the Securities and Exchange Commission at http://www.sec.gov. Free copies
of these documents may also be obtained from Evotec, by directing a request
to Evotec's Investor Relations department at Schnackenburgallee 114, 22525
Hamburg, Germany, or from Renovis, by directing a request to Renovis'
|SOURCE Evotec AG|
Copyright©2008 PR Newswire.
All rights reserved